2024-04-012025-03-312025-03-31false11459678CLEANZYME LTD2025-12-09falseiso4217:GBPxbrli:pure114596782024-03-31114596782025-03-31114596782024-04-012025-03-31114596782023-03-31114596782024-03-31114596782023-04-012024-03-3111459678bus:SmallEntities2024-04-012025-03-3111459678bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3111459678bus:FullAccounts2024-04-012025-03-3111459678bus:PrivateLimitedCompanyLtd2024-04-012025-03-3111459678core:WithinOneYear2025-03-3111459678core:AfterOneYear2025-03-3111459678core:WithinOneYear2024-03-3111459678core:AfterOneYear2024-03-3111459678core:ShareCapital2025-03-3111459678core:SharePremium2025-03-3111459678core:RevaluationReserve2025-03-3111459678core:OtherReservesSubtotal2025-03-3111459678core:RetainedEarningsAccumulatedLosses2025-03-3111459678core:ShareCapital2024-03-3111459678core:SharePremium2024-03-3111459678core:RevaluationReserve2024-03-3111459678core:OtherReservesSubtotal2024-03-3111459678core:RetainedEarningsAccumulatedLosses2024-03-3111459678core:LandBuildings2025-03-3111459678core:PlantMachinery2025-03-3111459678core:Vehicles2025-03-3111459678core:FurnitureFittings2025-03-3111459678core:OfficeEquipment2025-03-3111459678core:NetGoodwill2025-03-3111459678core:IntangibleAssetsOtherThanGoodwill2025-03-3111459678core:ListedExchangeTraded2025-03-3111459678core:UnlistedNon-exchangeTraded2025-03-3111459678core:LandBuildings2024-03-3111459678core:PlantMachinery2024-03-3111459678core:Vehicles2024-03-3111459678core:FurnitureFittings2024-03-3111459678core:OfficeEquipment2024-03-3111459678core:NetGoodwill2024-03-3111459678core:IntangibleAssetsOtherThanGoodwill2024-03-3111459678core:ListedExchangeTraded2024-03-3111459678core:UnlistedNon-exchangeTraded2024-03-3111459678core:LandBuildings2024-04-012025-03-3111459678core:PlantMachinery2024-04-012025-03-3111459678core:Vehicles2024-04-012025-03-3111459678core:FurnitureFittings2024-04-012025-03-3111459678core:OfficeEquipment2024-04-012025-03-3111459678core:NetGoodwill2024-04-012025-03-3111459678core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111459678core:ListedExchangeTraded2024-04-012025-03-3111459678core:UnlistedNon-exchangeTraded2024-04-012025-03-3111459678core:MoreThanFiveYears2024-04-012025-03-3111459678core:Non-currentFinancialInstruments2025-03-3111459678core:Non-currentFinancialInstruments2024-03-3111459678dpl:CostSales2024-04-012025-03-3111459678dpl:DistributionCosts2024-04-012025-03-3111459678core:LandBuildings2024-04-012025-03-3111459678core:PlantMachinery2024-04-012025-03-3111459678core:Vehicles2024-04-012025-03-3111459678core:FurnitureFittings2024-04-012025-03-3111459678core:OfficeEquipment2024-04-012025-03-3111459678dpl:AdministrativeExpenses2024-04-012025-03-3111459678core:NetGoodwill2024-04-012025-03-3111459678core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111459678dpl:GroupUndertakings2024-04-012025-03-3111459678dpl:ParticipatingInterests2024-04-012025-03-3111459678dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3111459678core:ListedExchangeTraded2024-04-012025-03-3111459678dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3111459678core:UnlistedNon-exchangeTraded2024-04-012025-03-3111459678dpl:CostSales2023-04-012024-03-3111459678dpl:DistributionCosts2023-04-012024-03-3111459678core:LandBuildings2023-04-012024-03-3111459678core:PlantMachinery2023-04-012024-03-3111459678core:Vehicles2023-04-012024-03-3111459678core:FurnitureFittings2023-04-012024-03-3111459678core:OfficeEquipment2023-04-012024-03-3111459678dpl:AdministrativeExpenses2023-04-012024-03-3111459678core:NetGoodwill2023-04-012024-03-3111459678core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3111459678dpl:GroupUndertakings2023-04-012024-03-3111459678dpl:ParticipatingInterests2023-04-012024-03-3111459678dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3111459678core:ListedExchangeTraded2023-04-012024-03-3111459678dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3111459678core:UnlistedNon-exchangeTraded2023-04-012024-03-3111459678core:NetGoodwill2025-03-3111459678core:IntangibleAssetsOtherThanGoodwill2025-03-3111459678core:LandBuildings2025-03-3111459678core:PlantMachinery2025-03-3111459678core:Vehicles2025-03-3111459678core:FurnitureFittings2025-03-3111459678core:OfficeEquipment2025-03-3111459678core:AfterOneYear2025-03-3111459678core:WithinOneYear2025-03-3111459678core:ListedExchangeTraded2025-03-3111459678core:UnlistedNon-exchangeTraded2025-03-3111459678core:ShareCapital2025-03-3111459678core:SharePremium2025-03-3111459678core:RevaluationReserve2025-03-3111459678core:OtherReservesSubtotal2025-03-3111459678core:RetainedEarningsAccumulatedLosses2025-03-3111459678core:NetGoodwill2024-03-3111459678core:IntangibleAssetsOtherThanGoodwill2024-03-3111459678core:LandBuildings2024-03-3111459678core:PlantMachinery2024-03-3111459678core:Vehicles2024-03-3111459678core:FurnitureFittings2024-03-3111459678core:OfficeEquipment2024-03-3111459678core:AfterOneYear2024-03-3111459678core:WithinOneYear2024-03-3111459678core:ListedExchangeTraded2024-03-3111459678core:UnlistedNon-exchangeTraded2024-03-3111459678core:ShareCapital2024-03-3111459678core:SharePremium2024-03-3111459678core:RevaluationReserve2024-03-3111459678core:OtherReservesSubtotal2024-03-3111459678core:RetainedEarningsAccumulatedLosses2024-03-3111459678core:NetGoodwill2023-03-3111459678core:IntangibleAssetsOtherThanGoodwill2023-03-3111459678core:LandBuildings2023-03-3111459678core:PlantMachinery2023-03-3111459678core:Vehicles2023-03-3111459678core:FurnitureFittings2023-03-3111459678core:OfficeEquipment2023-03-3111459678core:AfterOneYear2023-03-3111459678core:WithinOneYear2023-03-3111459678core:ListedExchangeTraded2023-03-3111459678core:UnlistedNon-exchangeTraded2023-03-3111459678core:ShareCapital2023-03-3111459678core:SharePremium2023-03-3111459678core:RevaluationReserve2023-03-3111459678core:OtherReservesSubtotal2023-03-3111459678core:RetainedEarningsAccumulatedLosses2023-03-3111459678core:AfterOneYear2024-04-012025-03-3111459678core:WithinOneYear2024-04-012025-03-3111459678core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3111459678core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3111459678core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3111459678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3111459678core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3111459678core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3111459678core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111459678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111459678core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111459678core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3111459678core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3111459678core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3111459678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3111459678core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3111459678core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3111459678core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3111459678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3111459678core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3111459678core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3111459678core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3111459678core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3111459678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3111459678core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3111459678core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3111459678core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3111459678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3111459678core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3111459678bus:Director12024-04-012025-03-31

CLEANZYME LTD

Registered Number
11459678
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

CLEANZYME LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

STOREY, James Scott

Registered Address

Bartle House
9 Oxford Court
Manchester
M2 3WQ

Registered Number

11459678 (England and Wales)
CLEANZYME LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Current assets
Stocks3-1,150
Debtors3,6664,431
Cash at bank and on hand7,2199,151
10,88514,732
Creditors amounts falling due within one year4(7,993)(6,796)
Net current assets (liabilities)2,8927,936
Total assets less current liabilities2,8927,936
Creditors amounts falling due after one year5(7,648)(10,767)
Net assets(4,756)(2,831)
Capital and reserves
Called up share capital100100
Profit and loss account(4,856)(2,931)
Shareholders' funds(4,756)(2,831)
The financial statements were approved and authorised for issue by the Director on 9 December 2025, and are signed on its behalf by:
STOREY, James Scott
Director
Registered Company No. 11459678
CLEANZYME LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20252024
Average number of employees during the year11
3.Stocks

2025

2024

££
Other stocks-1,150
Total-1,150
4.Creditors: amounts due within one year

2025

2024

££
Bank borrowings and overdrafts5,0074,902
Other creditors1,4501,138
Accrued liabilities and deferred income1,536756
Total7,9936,796
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts7,64810,767
Total7,64810,767